S&P 500 component Intuitive Surgical Inc.
reported net income above Wall Street’s expectations for the fourth quarter. Intuitive Surgical designs and manufactures da Vinci Surgical Systems, EndoWrist instruments and other surgical accessories.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Intuitive Surgical Earnings Cheat Sheet for the Fourth Quarter .
Results: Net income for Intuitive Surgical Inc. rose to $151.2 million ($3.75 per share) vs. $121.2 million ($3.02 per share) in the same quarter a year earlier. This marks a rise of 24.8% from the year earlier quarter.
Revenue: Rose 27.6% to $496.8 million from the year earlier quarter.
Actual vs. Wall St. Expectations: ISRG beat the mean analyst estimate of $3.34 per share. It beat the average revenue estimate of $483.7 million.
Quoting Management: “We ended fiscal 2011 with $2,172 million in cash, cash equivalents and investments, reflecting an increase of $563 million during the year, net of $332 million used to repurchase 963,000 shares of common stock. Commenting on the announcement, Dr. Gary Guthart, President and CEO of Intuitive Surgical, said, “We are pleased with our fourth quarter performance. These results reflect continued da Vinci procedure adoption, highlighted by strong growth in our US gynecology business, and a focus on execution by our commercial and product operations teams.”
Looking forward to 2012!
reported net income above Wall Street’s expectations for the fourth quarter. Intuitive Surgical designs and manufactures da Vinci Surgical Systems, EndoWrist instruments and other surgical accessories.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Intuitive Surgical Earnings Cheat Sheet for the Fourth Quarter .
Results: Net income for Intuitive Surgical Inc. rose to $151.2 million ($3.75 per share) vs. $121.2 million ($3.02 per share) in the same quarter a year earlier. This marks a rise of 24.8% from the year earlier quarter.
Revenue: Rose 27.6% to $496.8 million from the year earlier quarter.
Actual vs. Wall St. Expectations: ISRG beat the mean analyst estimate of $3.34 per share. It beat the average revenue estimate of $483.7 million.
Quoting Management: “We ended fiscal 2011 with $2,172 million in cash, cash equivalents and investments, reflecting an increase of $563 million during the year, net of $332 million used to repurchase 963,000 shares of common stock. Commenting on the announcement, Dr. Gary Guthart, President and CEO of Intuitive Surgical, said, “We are pleased with our fourth quarter performance. These results reflect continued da Vinci procedure adoption, highlighted by strong growth in our US gynecology business, and a focus on execution by our commercial and product operations teams.”
Looking forward to 2012!